The Efficacy of Probiotics as an Adjunct to Treatment of SIBO With Rifaximin
A legfontosabb adatok
- Ki végzi
- Pomeranian Medical University Szczecin
- Hol
- Lengyelország1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 129 fő vett részt
- Kezdés
- 2023. ápr. 1.
- Befejezés
- 2025. aug. 30.
- A vizsgálat típusa
- Beavatkozással járó, 5 csoportAz egyik csoport placebót (hatóanyag nélküli szert) kap, összehasonlításként.
- A vizsgált kezelések
- Rifaximin (Xifaxan) 1200mg/day
- Probiotic
- XIFAXAN® (Rifaximin) 1600mg/day
- A regiszteradat frissítve
- 2025. december 4.
Ki vehet részt
- Életkor
- 18 év – 70 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 17 feltétel megnézéseKevesebb
Ki vehet részt
- positive hydrogen OR methane breath test
- SIBO symptoms seen as:; moderate or severe bloating for at least 50% of days in the past 3 months if hydrogen test (+) OR constipation (< 3 bowel movements/week) in the past 3 months if methane test (+)
Ki nem vehet részt
- current proton pump inhibitor therapy,
- antibiotic therapy in the past 3 months,
- probiotic therapy in the past 2 weeks,
- hepatitis B or C virus infection,
- other liver disease,
- celiac disease,
- severe chronic disease (m.e.g. chronic kidney disease, congestive heart failure, cancer, liver failure),
- current symptoms of acute infection,
- age <18
- age >70,
- daily intake of >30 g of ethanol for men
- daily intake of >20 g of ethanol for women,
- pregnancy,
- vegan diet or following non-recommended diets such as ketogenic,
- patients with very high physical activity (> 5 x week of 100 min of strength training)
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
The goal of this clinical trial is to test the effectiveness of probiotic bacterial supplements as an additional therapeutic modality in patients with small intestine bacterial overgrowth who receive oral antibiotic treatment (rifaximin)
A teljes eredeti leírásKevesebb
The main questions it aims to answer are:
1 To evaluate the effectiveness of a dietary intervention using pro-biotic bacterial strains as an adjunct to treatment of SIBO with rifaximin.
2. Evaluation of ultrasonographic imaging of mesenteric lymph nodes in patients with SIBO.
3. Evaluation of the effect of rifaximin treatment and dietary intervention on non-alcoholic fatty liver disease activity parameters in patients with coexisting NAFLD and SIBO.
According to the study schedule, a total of 3 visits will be made within 3 months. Visit 1, after 6 weeks Visit 2 and after another 6 weeks, Visit 3. Patients will also be invited to a follow-up Visit 4, three months after completing participation in the study.
All study participants will receive treatment recommendations for SIBO in accordance with standard practice - a 14-day antibiotic treatment with Rifaximin.
In addition, a randomly selected half of the study participants will receive probiotic therapy and half a placebo.
* An ultrasound examination of the mesenteric root lymph nodes will be performed at each visit, * followed by a lier steatosis/fibrosis assessment using SWE elastography or FibroScan. * Blood sampling is required on each visit. All study participants will receive detailed guidelines during dietary consultations at each visit for the use of a low FODMAP diet. * Each participant will receive a paper diary on how to assess the severity of bloating and evaluate bowel movements, which must be filled out daily. * In addition, at the visits the patient will be asked to fill out an additional questionnaire on other gastrointestinal complaints and mental health.
A vizsgálat 5 csoportja
- Probiotic+Rifaximin 1200mg/dayA vizsgált kezelés
Dosage 2x1 capsule/day. 12 weeks Probiotic, which will contain a combination of four freeze-dried strains of probiotic bacteria in DRcaps enteral capsulesTM . These are capsules that protect the probiotics from the effects of hydrochloric acid in the stomach, as they only dissolve in the intestines. The tested composition of probiotics is on sale in Poland, Italy, Taiwan, among other countries. It has a positive recommendation of the Institute "Pomnik-Center for Children's Health" No. 16/DJW/2022. (Lactococcus lactis Rosell® - 1058, Lactobacillus casei Rosell® - 215, Lactobacillus helvetius Rosell® - 52, Bifidobacterium bifidum Rosell® - 71) AND Rifaximin at a dose of 1200 mg/d for 14 days (Xifaxan 200 mg, 3 op. of 28 tablets, DS. 3 x 400mg)
Kezelés: Rifaximin (Xifaxan) 1200mg/day és Probiotic
- Placebo+Rifaximin 1600mg/dayPlacebo, összehasonlításként
Capsules that look identical to the probiotic and contain potato starch and a shell: hydroxypropylmethylcellulose, gellan gum. Dosage 2x1 capsule per day. 12 weeks AND Rifaximin at a dose of 1600 mg/d for 14 days (Xifaxan 200 mg, 4 op. of 28 tablets, DS. 4 x 400mg)
Kezelés: XIFAXAN® (Rifaximin) 1600mg/day
- Control groupNincs vizsgálati kezelés, összehasonlításként
The control group will consist of healthy subjects (25 subjects) without SIBO (with a negative hydrogen-methane test) and without NAFLD (CAP\<248dB/m, TE\<6.5kPa).
- Probiotic + Rifaximin 1600mg/dayA vizsgált kezelés
Dosage 2x1 capsule/day. 12 weeks Probiotic, which will contain a combination of four freeze-dried strains of probiotic bacteria in DRcaps enteral capsulesTM . These are capsules that protect the probiotics from the effects of hydrochloric acid in the stomach, as they only dissolve in the intestines. The tested composition of probiotics is on sale in Poland, Italy, Taiwan, among other countries. It has a positive recommendation of the Institute "Pomnik-Center for Children's Health" No. 16/DJW/2022. (Lactococcus lactis Rosell® - 1058, Lactobacillus casei Rosell® - 215, Lactobacillus helvetius Rosell® - 52, Bifidobacterium bifidum Rosell® - 71) AND Rifaximin at a dose of 1600 mg/d for 14 days (Xifaxan 200 mg, 4 op. of 28 tablets, DS. 4 x 400mg)
Kezelés: Probiotic és XIFAXAN® (Rifaximin) 1600mg/day
- Placebo+Rifaximin 1200mg/dayPlacebo, összehasonlításként
Capsules that look identical to the probiotic and contain potato starch and a shell: hydroxypropylmethylcellulose, gellan gum. Dosage 2x1 capsule per day. 12 weeks AND Rifaximin at a dose of 1200 mg/d for 14 days (Xifaxan 200 mg, 3 op. of 28 tablets, DS. 3 x 400mg)
Kezelés: Rifaximin (Xifaxan) 1200mg/day
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Randomized, Double-blind, Placebo-Controlled Study on Efficacy of a Dietary Intervention With Probiotic Bacterial Strains as an Adjunct to Treatment of Small Intestinal Bacterial Overgrowth With Rifaximin
- A regiszteradat frissítve
- 2025. december 4.